Lithium Carbonate 300mg Capsules

Manufacturer GLENMARK PHARMACEUTICALS Active Ingredient Lithium Capsules and Tablets(LITH ee um) Pronunciation LITH ee um KAR bo nate
WARNING: This drug may cause severe side effects at doses that are close to the normal dose. Rarely, this may include death. Do not take more of this drug than you are told. You will have blood tests to check the level of this drug in your blood. There are many signs of too much lithium in the blood. Closely read the part in this leaflet which lists when to call your doctor. @ COMMON USES: It is used to treat bipolar disorder. It may be given to you for other reasons. Talk with the doctor.
đŸˇī¸
Drug Class
Antimanic agent, mood stabilizer
đŸ§Ŧ
Pharmacologic Class
Alkali metal ion
🤰
Pregnancy Category
Category D
✅
FDA Approved
Jan 1970
âš–ī¸
DEA Schedule
Not Controlled

Overview

â„šī¸

What is this medicine?

Lithium is a medication used to treat and prevent episodes of mania (extreme excitement or irritability) in people with bipolar disorder. It helps to stabilize mood and reduce the severity and frequency of mood swings. It's an alkali metal that works in the brain to help balance certain chemicals.
📋

How to Use This Medicine

Taking Your Medication

To use this medication correctly, follow your doctor's instructions and read all the information provided. You can take this medication with or without food, but if it causes stomach upset, take it with food. Maintain a consistent salt intake from day to day. Also, follow your doctor's advice on the type and amount of liquids to drink while taking this medication.

Storing and Disposing of Your Medication

Store this medication at room temperature in a dry place, avoiding the bathroom. Keep all medications in a safe location, out of the reach of children and pets. Dispose of unused or expired medications properly. Do not flush them down the toilet or pour them down the drain unless instructed to do so. If you have questions about disposal, consult your pharmacist, who can also inform you about potential drug take-back programs in your area.

What to Do If You Miss a Dose

If you miss a dose, take it as soon as you remember. However, if it's close to the time for your next dose, skip the missed dose and resume your regular schedule. Avoid taking two doses at the same time or taking extra doses. If you're unsure about what to do if you miss a dose, contact your doctor for guidance.
💡

Lifestyle & Tips

  • Maintain consistent fluid intake (8-12 glasses of water daily) to prevent dehydration, which can increase lithium levels and toxicity.
  • Maintain consistent sodium intake; avoid drastic changes in diet (e.g., very low sodium diets) as this can affect lithium levels.
  • Avoid excessive caffeine intake, as it can increase lithium excretion.
  • Be aware of conditions that can cause dehydration (e.g., fever, vomiting, diarrhea, heavy sweating from exercise or hot weather) and seek medical advice if they occur, as dose adjustments may be needed.
  • Do not stop taking lithium suddenly, as this can lead to a relapse of symptoms.
  • Attend all scheduled appointments for blood tests and doctor visits.

Dosing & Administration

đŸ‘¨â€âš•ī¸

Adult Dosing

Standard Dose: Initial: 300 mg orally 2-3 times daily. Maintenance: 300 mg orally 3-4 times daily or 450 mg extended-release orally 2 times daily.
Dose Range: 600 - 1800 mg

Condition-Specific Dosing:

acuteMania: Initial: 600 mg orally 3 times daily (1800 mg/day) or 900 mg extended-release orally 2 times daily (1800 mg/day). Target serum levels: 0.8-1.2 mEq/L.
maintenance: Initial: 300 mg orally 3-4 times daily (900-1200 mg/day) or 450 mg extended-release orally 2 times daily (900 mg/day). Target serum levels: 0.6-1.0 mEq/L.
đŸ‘ļ

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: Limited data; generally not recommended for children under 12 years. If used, individualized dosing based on weight and serum levels. Initial: 15-20 mg/kg/day in divided doses. Target serum levels: 0.6-1.2 mEq/L.
Adolescent: Similar to adult dosing, but start with lower doses and titrate based on serum levels and clinical response. Initial: 300 mg orally 2-3 times daily. Target serum levels: 0.6-1.2 mEq/L.
âš•ī¸

Dose Adjustments

Renal Impairment:

Mild: Reduce dose by 25-50% or extend dosing interval. Monitor serum levels closely.
Moderate: Reduce dose by 50-75% or extend dosing interval significantly. Monitor serum levels closely.
Severe: Contraindicated or use with extreme caution and significant dose reduction (e.g., 75% or more). Monitor serum levels daily.
Dialysis: Lithium is dialyzable. Administer dose after dialysis. Monitor serum levels closely.

Hepatic Impairment:

Mild: No specific adjustment needed as lithium is not hepatically metabolized.
Moderate: No specific adjustment needed.
Severe: No specific adjustment needed.

Pharmacology

đŸ”Ŧ

Mechanism of Action

The precise mechanism of action of lithium in bipolar disorder is not fully understood. It is thought to exert its therapeutic effects through multiple mechanisms, including: modulation of neurotransmitter systems (e.g., serotonin, norepinephrine, dopamine), inhibition of inositol monophosphatase (leading to depletion of inositol and disruption of phosphoinositide signaling), inhibition of glycogen synthase kinase-3 beta (GSK-3β), and effects on ion transport (e.g., sodium-potassium ATPase). These actions collectively contribute to mood stabilization.
📊

Pharmacokinetics

Absorption:

Bioavailability: Nearly 100%
Tmax: 0.5-3 hours (immediate release); 4-6 hours (extended release)
FoodEffect: Food may delay absorption but does not significantly affect the extent of absorption. Taking with food may reduce GI upset.

Distribution:

Vd: 0.7-0.9 L/kg (similar to total body water)
ProteinBinding: 0%
CnssPenetration: Limited (slowly crosses blood-brain barrier, reaching equilibrium with plasma after 6-24 hours)

Elimination:

HalfLife: 18-36 hours (longer in elderly and renal impairment)
Clearance: Primarily renal clearance, varies with renal function and sodium intake.
ExcretionRoute: Renal (primarily via glomerular filtration, with 80% reabsorbed in the proximal tubules)
Unchanged: >95%
âąī¸

Pharmacodynamics

OnsetOfAction: Mood stabilization: 1-3 weeks (for full therapeutic effect)
PeakEffect: Acute antimanic effect: 1-3 weeks
DurationOfAction: Dependent on half-life and consistent dosing; effects persist as long as therapeutic levels are maintained.

Safety & Warnings

âš ī¸

BLACK BOX WARNING

Lithium toxicity is closely related to serum lithium levels and can occur at doses close to therapeutic levels. Facilities for prompt and accurate serum lithium determinations should be available. Patients should be cautioned to avoid conditions that may lead to dehydration and a reduction in sodium intake (e.g., excessive sweating, diarrhea, vomiting, fever), which can increase lithium levels and the risk of toxicity.
âš ī¸

Side Effects

Serious Side Effects: Seek Medical Help Right Away

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor immediately or seek emergency medical attention:

Signs of an allergic reaction, such as:
+ Rash or hives
+ Itching or red, swollen, blistered, or peeling skin (with or without fever)
+ Wheezing or tightness in the chest or throat
+ Difficulty breathing, swallowing, or talking
+ Unusual hoarseness or swelling of the mouth, face, lips, tongue, or throat
Signs of acidosis (too much acid in the blood), such as:
+ Confusion
+ Rapid breathing or heartbeat
+ Abnormal heartbeat or very severe stomach pain
+ Nausea, vomiting, or feeling extremely sleepy
+ Shortness of breath or feeling very tired or weak
Signs of thyroid problems, such as:
+ Weight changes
+ Feeling nervous, excitable, restless, or weak
+ Hair thinning or depression
+ Eye or neck swelling
+ Difficulty focusing or trouble with heat or cold
+ Menstrual changes or shakiness
+ Excessive sweating
Signs of fluid and electrolyte problems, such as:
+ Mood changes or confusion
+ Muscle pain or weakness
+ Abnormal heartbeat or severe dizziness
+ Increased thirst or seizures
+ Feeling very tired or weak
+ Decreased appetite or difficulty urinating
+ Dry mouth, dry eyes, or severe stomach upset
Other serious side effects, such as:
+ Bloating or diarrhea
+ Dizziness or giddiness
+ Difficulty walking or controlling body movements
+ Twitching, balance problems, or trouble swallowing or speaking
+ Muscle weakness or feeling sluggish
+ Uncontrolled eye movements
+ Mood changes or fever
+ Hallucinations (seeing or hearing things that are not there)
+ Memory problems or loss
+ Restlessness or shortness of breath
+ Sudden weight gain or swelling in the arms or legs
+ Unexplained weight changes
+ Loss of bladder or bowel control
+ Sexual problems

Common Side Effects

Most people experience few or no side effects while taking this medication. However, if you notice any of the following side effects, contact your doctor if they bother you or do not go away:

Feeling dizzy, sleepy, tired, or weak
Upset stomach or decreased appetite
Stomach pain or excessive saliva production
Gas or dry mouth
Headache or dry, thin, or falling hair
* Joint pain or changes in taste

Reporting Side Effects

If you have questions or concerns about side effects, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Early signs of toxicity: Nausea, vomiting, diarrhea, fine tremor, muscle weakness, drowsiness, thirst, increased urination.
  • Moderate to severe toxicity: Coarse tremor, ataxia (loss of coordination), slurred speech, confusion, blurred vision, ringing in ears, muscle twitching, seizures, coma.
  • Signs of hypothyroidism: Fatigue, weight gain, constipation, feeling cold, dry skin, hair loss.
  • Signs of kidney problems: Increased thirst and urination (polyuria/polydipsia).
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the symptoms you experienced.
Certain health conditions, including:
+ Dehydration (fluid loss)
+ Heart disease
+ Kidney disease
+ Low sodium levels in your blood
+ Severe illness or weakness
A specific heart condition called Brugada syndrome, or if you have ever fainted without knowing the reason
A family history of Brugada syndrome or sudden death before the age of 45
* If you are taking medications for blood pressure or heart problems, as your doctor may need to monitor your blood work more closely

This list is not exhaustive, and it is crucial to discuss all your medications (prescription, over-the-counter, natural products, and vitamins) and health problems with your doctor and pharmacist. They will help determine if it is safe to take this medication with your other medications and health conditions. Never start, stop, or change the dose of any medication without first consulting your doctor.
âš ī¸

Precautions & Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication. Regular blood tests will be necessary, as directed by your doctor, to monitor your condition. Be sure to discuss any concerns or questions with your doctor.

Until you know how this medication affects you, avoid driving and other activities that require alertness. If you are advised to follow a low-salt diet, notify your doctor, as this can impact how your body processes lithium. Additionally, consult your doctor before consuming alcohol.

Certain conditions, such as fever, infection, vomiting, diarrhea, or excessive sweating, can alter the levels of this medication in your blood. If you experience any of these conditions, inform your doctor promptly. It is also crucial to stay hydrated, especially in hot weather or during physical activity, to prevent fluid loss.

Monitor your body for signs of high blood sugar, including confusion, drowsiness, unusual thirst or hunger, frequent urination, flushing, rapid breathing, or fruity-smelling breath. If you notice any of these symptoms, report them to your doctor.

There is a rare risk of a heart condition called Brugada Syndrome, which can increase the risk of sudden death. Although this condition is often undiagnosed, it is essential to discuss this potential risk with your doctor. In some cases, people taking this medication with other drugs, such as haloperidol, have experienced rare brain problems, which can lead to long-term brain damage. Consult your doctor about this potential risk.

A severe and potentially life-threatening condition called serotonin syndrome can occur, especially when taking certain other medications. Seek immediate medical attention if you experience agitation, balance problems, confusion, hallucinations, fever, abnormal heartbeat, flushing, muscle twitching or stiffness, seizures, shivering or shaking, excessive sweating, severe diarrhea, nausea or vomiting, or a severe headache.

This medication can also cause increased pressure in the brain and swelling in the eyes, leading to vision problems, including loss of vision. If you experience a severe headache, ringing in the ears, or vision problems such as blurred vision, double vision, or loss of vision, contact your doctor immediately.

If you notice signs of kidney problems, such as difficulty urinating, changes in urine output, bloody, brown, or foamy urine, shortness of breath, cough, or swelling in the face, feet, or hands, seek medical attention promptly.

If you are 65 or older, use this medication with caution, as you may be more susceptible to side effects. This medication can harm an unborn baby, so a pregnancy test may be required before starting treatment. If you become pregnant or are planning to become pregnant, inform your doctor immediately. Additionally, if you are breastfeeding or plan to breastfeed, consult your doctor, as this medication can pass into breast milk and potentially harm your baby.
🆘

Overdose Information

Overdose Symptoms:

  • Severe nausea, vomiting, and diarrhea
  • Coarse tremor
  • Ataxia (unsteady gait)
  • Slurred speech
  • Confusion, lethargy, stupor
  • Muscle twitching or fasciculations
  • Hyperreflexia
  • Seizures
  • Cardiac arrhythmias
  • Coma
  • Renal failure

What to Do:

Seek immediate medical attention or call Poison Control (1-800-222-1222). Treatment may involve gastric lavage, whole bowel irrigation, correction of fluid and electrolyte imbalances, and in severe cases, hemodialysis to remove lithium from the body.

Drug Interactions

🔴

Major Interactions

  • Thiazide diuretics (e.g., hydrochlorothiazide): Increase lithium reabsorption, leading to increased lithium levels and toxicity.
  • Loop diuretics (e.g., furosemide): Can increase or decrease lithium levels; monitor closely.
  • NSAIDs (e.g., ibuprofen, naproxen, celecoxib): Decrease renal clearance of lithium, leading to increased lithium levels and toxicity.
  • ACE inhibitors (e.g., lisinopril, enalapril): Decrease renal clearance of lithium, leading to increased lithium levels and toxicity.
  • Angiotensin Receptor Blockers (ARBs) (e.g., valsartan, losartan): Decrease renal clearance of lithium, leading to increased lithium levels and toxicity.
  • Metronidazole: Can increase lithium levels and toxicity.
  • Serotonergic drugs (e.g., SSRIs, SNRIs, triptans, MAOIs): Increased risk of serotonin syndrome.
  • Calcium channel blockers (e.g., verapamil, diltiazem): Increased risk of neurotoxicity (ataxia, tremor, nausea, vomiting, diarrhea) even at therapeutic lithium levels.
  • Phenytoin: Can increase lithium levels and neurotoxicity.
  • Carbamazepine: Increased risk of neurotoxicity (ataxia, tremor, nausea, vomiting, diarrhea) even at therapeutic lithium levels.
🟡

Moderate Interactions

  • Caffeine: May increase lithium excretion, potentially lowering lithium levels.
  • Theophylline: May increase lithium excretion, potentially lowering lithium levels.
  • Sodium-containing products (e.g., high sodium diet, IV saline): Can increase lithium excretion, potentially lowering lithium levels.
  • Sodium-depleting conditions (e.g., dehydration, excessive sweating, vomiting, diarrhea): Can decrease lithium excretion, leading to increased lithium levels and toxicity.
  • Antipsychotics (e.g., haloperidol, clozapine): Increased risk of neurotoxicity, especially with haloperidol.
  • Methyldopa: Can increase lithium levels and toxicity.
  • Topiramate: May increase lithium levels.
đŸŸĸ

Minor Interactions

  • Acetazolamide: May increase lithium excretion.
  • Urea: May increase lithium excretion.

Monitoring

đŸ”Ŧ

Baseline Monitoring

Renal function (BUN, serum creatinine, eGFR)

Rationale: Lithium is primarily renally eliminated; renal impairment increases risk of toxicity.

Timing: Prior to initiation

Thyroid function (TSH, free T4)

Rationale: Lithium can cause hypothyroidism.

Timing: Prior to initiation

Electrolytes (sodium, potassium, calcium)

Rationale: Electrolyte imbalances, especially sodium, can affect lithium levels.

Timing: Prior to initiation

ECG

Rationale: Lithium can cause cardiac conduction abnormalities (e.g., T-wave flattening/inversion); recommended for patients with cardiac risk factors.

Timing: Prior to initiation (if indicated)

Pregnancy test (for females of childbearing potential)

Rationale: Lithium is Category D in pregnancy.

Timing: Prior to initiation

Weight/BMI

Rationale: Lithium can cause weight gain.

Timing: Prior to initiation

📊

Routine Monitoring

Serum Lithium Levels

Frequency: 5 days after initiation or dose change, then weekly until stable, then every 3-6 months (or more frequently if clinically indicated, e.g., illness, dehydration, new medications).

Target: Acute Mania: 0.8-1.2 mEq/L; Maintenance: 0.6-1.0 mEq/L (trough levels, drawn 10-12 hours post-dose).

Action Threshold: >1.5 mEq/L (mild toxicity), >2.0 mEq/L (moderate toxicity), >2.5 mEq/L (severe toxicity) - requires immediate intervention.

Renal function (BUN, serum creatinine, eGFR)

Frequency: Every 6-12 months (or more frequently if renal impairment or risk factors).

Target: Within normal limits for age/sex.

Action Threshold: Significant decline in eGFR or increase in creatinine - consider dose reduction or discontinuation.

Thyroid function (TSH)

Frequency: Every 6-12 months (or more frequently if symptoms of hypothyroidism).

Target: Within normal limits.

Action Threshold: Elevated TSH - consider thyroid hormone replacement.

Electrolytes (sodium)

Frequency: Periodically, especially if changes in hydration or diet.

Target: Within normal limits.

Action Threshold: Hyponatremia - increases risk of lithium toxicity.

Weight/BMI

Frequency: Annually or as clinically indicated.

Target: Stable.

Action Threshold: Significant weight gain - consider dietary counseling or alternative.

đŸ‘ī¸

Symptom Monitoring

  • Signs of lithium toxicity (nausea, vomiting, diarrhea, tremor, ataxia, slurred speech, confusion, lethargy, muscle weakness, seizures, coma)
  • Signs of hypothyroidism (fatigue, weight gain, constipation, cold intolerance, dry skin, hair loss)
  • Signs of nephrogenic diabetes insipidus (polyuria, polydipsia)
  • Changes in mood or behavior (for efficacy and relapse)

Special Patient Groups

🤰

Pregnancy

Lithium is classified as Pregnancy Category D. It crosses the placenta and has been associated with an increased risk of congenital malformations, particularly Ebstein's anomaly (a rare heart defect), though the absolute risk is lower than previously estimated. Use during pregnancy should be carefully weighed against the risks of untreated bipolar disorder. If used, monitor lithium levels closely as they can fluctuate significantly during pregnancy.

Trimester-Specific Risks:

First Trimester: Highest risk for cardiac malformations (Ebstein's anomaly) if exposed during the first trimester (especially weeks 4-8 of gestation).
Second Trimester: Lower risk of malformations, but continued exposure can lead to fetal lithium toxicity (e.g., hypotonia, lethargy, cyanosis, goiter) and polyhydramnios.
Third Trimester: Risk of neonatal lithium toxicity (e.g., hypotonia, lethargy, cyanosis, poor feeding, cardiac arrhythmias, diabetes insipidus-like syndrome) if exposed near term. Maternal lithium levels often decrease in the third trimester due to increased renal clearance, requiring dose adjustments.
🤱

Lactation

Lithium is excreted into breast milk in significant amounts (milk-to-plasma ratio typically 0.3-0.5). The American Academy of Pediatrics considers lithium to be a drug for which the effect on the nursing infant is unknown but may be of concern. Most guidelines recommend avoiding breastfeeding if possible due to potential infant toxicity (lethargy, hypotonia, cyanosis, ECG changes, thyroid suppression). If breastfeeding is chosen, close monitoring of infant for signs of toxicity and regular infant lithium levels, renal function, and thyroid function are essential.

Infant Risk: L4 (Possibly Hazardous)
đŸ‘ļ

Pediatric Use

Generally not recommended for children under 12 years due to limited safety and efficacy data. If used, it should be under specialist supervision, with careful individualized dosing based on weight and frequent monitoring of serum levels, renal, and thyroid function. Higher incidence of side effects like tremor and polyuria/polydipsia may be observed.

👴

Geriatric Use

Elderly patients often have reduced renal clearance, leading to higher lithium levels at standard doses and an increased risk of toxicity. Start with lower doses (e.g., 300 mg once or twice daily) and titrate slowly based on serum levels and clinical response. More frequent monitoring of renal function, thyroid function, and lithium levels is crucial. They are also more susceptible to neurotoxic side effects.

Clinical Information

💎

Clinical Pearls

  • Lithium has a narrow therapeutic index; small changes in dose or fluid/sodium balance can lead to toxicity.
  • Consistency is key: Patients should take lithium at the same time each day and maintain consistent fluid and sodium intake.
  • Educate patients thoroughly on signs of toxicity and the importance of hydration and consistent sodium intake.
  • Always draw lithium levels 10-12 hours after the last dose (trough level) to ensure accurate interpretation.
  • Be vigilant for drug interactions, especially with diuretics, NSAIDs, ACE inhibitors, and ARBs, which can significantly increase lithium levels.
  • Long-term lithium use can cause renal impairment (e.g., chronic interstitial nephritis) and hypothyroidism; regular monitoring is essential.
  • Consider extended-release formulations for better adherence and potentially fewer peak-related side effects.
🔄

Alternative Therapies

  • Valproate (Divalproex sodium)
  • Carbamazepine
  • Lamotrigine
  • Atypical antipsychotics (e.g., olanzapine, quetiapine, risperidone, aripiprazole, lurasidone) for acute mania or maintenance in bipolar disorder.
💰

Cost & Coverage

Average Cost: Varies widely, typically $10-$50 per 30 capsules (300mg)
Generic Available: Yes
Insurance Coverage: Tier 1 or Tier 2 (Generic)
📚

General Drug Facts

If your symptoms or health issues persist or worsen, it is essential to contact your doctor promptly. To ensure safe and effective treatment, never share your medication with others or take someone else's medication. This medication is accompanied by a Medication Guide, which provides crucial information for patients. Please read this guide carefully and review it again whenever you receive a refill of this medication. If you have any questions or concerns about this medication, consult your doctor, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately call your local poison control center or seek emergency medical attention. When reporting the overdose, be prepared to provide details about the medication taken, the amount, and the time it occurred.